A detailed history of Mariner, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Mariner, LLC holds 10,812 shares of EBS stock, worth $86,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,812
Previous 11,012 1.82%
Holding current value
$86,171
Previous $91,000 13.19%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$7.72 - $11.97 $1,544 - $2,394
-200 Reduced 1.82%
10,812 $103,000
Q3 2024

Nov 13, 2024

SELL
$5.72 - $14.77 $451 - $1,166
-79 Reduced 0.71%
11,012 $91,000
Q2 2024

Aug 13, 2024

BUY
$1.86 - $6.98 $20,629 - $77,415
11,091 New
11,091 $75,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $397M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.